Presentation and Status in Health Basket
Presentation | Basket | Yarpa | Pharmasoft |
---|---|---|---|
Film Coated Tablets 60 X 250 mg |
21384 | 12440 | |
Film Coated Tablets 60 X 500 mg |
21385 | 12441 | |
Film Coated Tablets 60 X 1000 mg |
21386 | 12442 |
Related information
Dosage
See prescribing information for full details.
Indications
For adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in adults and children from 4 years of age with epilepsy.As adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. As monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients from 16 years of age with newly diagnosed epilepsy.
Treatment of primary generalized tonic-clonic seizures (PGTCS) in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
Contra-Indications
Hypersensitivity to levetiracetam or other pyrrolidone derivatives or any of the excipients. Not for use in children under 4 years of age.
Special Precautions
Avoid alcohol use during treatment.
See prescribing information for full details.
Side Effects
Drowsiness, weakness, fatigue.
See prescribing information for full details.
Drug interactions
See prescribing information for full details.